Pursuant to Second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech has informed the Board of Directors of the Company, in their meeting held on today Monday 20th December 2021 at the Registered Office of the Company and recommended the proposal of sub- division of Company’s shares from face Value of Rs 10 each per share to face Value of Rs 1 each per share.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1589.25 |
| Mangalam Global Ent | 12.93 |
| Kaveri Seed | 924.50 |
| Regaal Resources | 85.04 |
| Simran Farms | 165.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: